Non-invasive markers of fibrosis at 3 years of follow-up in liver transplant recipients with moderate/severe hepatitis C recurrence, successfully treated with DAAs. (February 2019) - Martini, S.; Sacco, M.; Testa, G.; Calvo, F.; Mirabella, S.; Cocchis, D.; Saracco, G.M.; Romagnoli, R.